マウザー、Omron Industrial AutomationのE3AS-HF ToFレーザーセンサの取り扱いを開始 新製品投入（New Product Introduction : NPI）の業界 ...

新製品投入（New Product Introduction: NPI）の業界リーダー(TM)として、イノベーションを推進するMouser Electronics(https://www.mouser.jp ...

新製品投入（New Product Introduction: NPI）の業界リーダー(TM)として、イノベーションを推進するMouser Electronics（マウザー・エレクトロニクス 本社：米国テキサス州マンスフィールド、以下マウザー）は、Omron Industrial Automation（本社：オムロン株式会社 京都市 ...

(UPDATED) Muddy conclusions from the GUIDE-HF trial hint that pulmonary artery pressure monitoring with the CardioMEMS device (Abbott) may help prevent heart failure (HF) hospitalizations in a broader ...

Endotronix presented positive six-month results from its PROACTIVE-HF pivotal trial of the investigational Cordella Pulmonary Artery (PA) Sensor on March 5. The trial, in New York Heart Association ...

TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., today announced that it has enrolled the first six patients in the VECTOR-HF II Study, which will evaluate the V-LAP System’s ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced its sensor providing hemodynamic-guided management of patients with HF has received an expanded ...

Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week ...

NAPERVILLE, Ill., March 5, 2024 /PRNewswire/ -- Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at the intersection of digital health and medtech, ...

The trial met primary safety and efficacy endpoints, demonstrating a markedly low rate of heart failure hospitalizations for NYHA class III HF patients. The results support the company's pre-market ...